Ornithine Alpha Ketoglutarate (OKG) Supplement - Precursor of Growth Hormone

Ornithine alpha ketoglutarate (OKG) is a compound that combines two molecules of the amino acid ornithine with one molecule of alpha ketoglutaric acid, an important component in the Krebs cycle. As a precursor of growth hormone, ornithine is twice as effective as arginine, now available to buy at Supersmart. OKG supplementation increases production of GH (growth hormone) and of IGF-1, an active, easy-to-measure derivative of GH.

What are the benefits associated with OKG supplementation?

• OKG has been used to promote growth in children of abnormally small stature (1).
• It also slows down loss of muscle mass in hospitalized patients and accelerates healing of serious burns (2).
• It increases protein synthesis and protects against muscular catabolism and is therefore particularly beneficial to sports enthusiasts and anyone wishing to promote their production of growth hormone.
• Studies show that OKG is particularly active in the mechanisms of ammonia detoxification: it combines with the ammonia produced during muscular exercise and thus improves recovery, helping to prevent cramps and stiffness.
• OKG is also an effective inhibitor of protein glycation (the process in which sugar molecules bond to proteins by 'cross-linking': these non-functional structures accelerate the ageing process).

Buy Ornithine alpha ketoglutarate (OKG) for muscle health benefits.

Other supplements of interest from Supersmart

As well as supplementing with Ornithine alpha ketoglutarate (OKG), you may find these other nutritional supplements of interest too.

Discover the properties of L-Glutamine, essential for protein synthesis with a key role in muscle activity. See also Ursolic Acid and its significant benefits for muscle mass and overall health.

1. Monkorzel, Goulet et al., Growth retardation in children receiving long term total parenteral nutrition: effects of ornithin alpha ketoglutarate, Am J Clin Nutr, 60(3): 408-13.1974 Sep.
2. De Bandt, Coudray-Lucas et al, a randomized controlled trial of the influence of the mode of enteral ornithine alpha-ketoglutarate administration in burn patients, J Nutr, 128(3):563-9 1998 Mar.